Detailed Information on Publication Record
2021
PLK1 regulates the PrimPol damage tolerance pathway during the cell cycle
BAILEY, Laura J., Rebecca TEAGUE, Peter KOLESÁR, Lewis J. BAINBRIDGE, Howard D. LINDSAY et. al.Basic information
Original name
PLK1 regulates the PrimPol damage tolerance pathway during the cell cycle
Authors
BAILEY, Laura J., Rebecca TEAGUE, Peter KOLESÁR (703 Slovakia, belonging to the institution), Lewis J. BAINBRIDGE, Howard D. LINDSAY and Aidan J. DOHERTY (guarantor)
Edition
Science Advances, New York, American Association for the Advancement of Science, 2021, 2375-2548
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10603 Genetics and heredity
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 14.957
RIV identification code
RIV/00216224:14310/21:00123896
Organization unit
Faculty of Science
UT WoS
000730595900005
Keywords in English
POLO-LIKE KINASE-1; MITOCHONDRIAL-DNA REPLICATION; FORK REVERSAL; POLYMERASE ETA; PHOSPHORYLATION; CATASTROPHE; BYPASS; REPAIR; DOMAIN; ROLES
Tags
International impact, Reviewed
Změněno: 21/1/2022 10:31, Mgr. Marie Šípková, DiS.
Abstract
V originále
Replication stress and DNA damage stall replication forks and impede genome synthesis. During S phase, damage tolerance pathways allow lesion bypass to ensure efficient genome duplication. One such pathway is repriming, mediated by Primase-Polymerase (PrimPol) in human cells. However, the mechanisms by which PrimPol is regulated are poorly understood. Here, we demonstrate that PrimPol is phosphorylated by Polo-like kinase 1 (PLK1) at a conserved residue between PrimPol's RPA binding motifs. This phosphorylation is differentially modified throughout the cell cycle, which prevents aberrant recruitment of PrimPol to chromatin. Phosphorylation can also be delayed and reversed in response to replication stress. The absence of PLK1-dependent regulation of PrimPol induces phenotypes including chromosome breaks, micronuclei, and decreased survival after treatment with camptothecin, olaparib, and UV-C. Together, these findings establish that deregulated repriming leads to genomic instability, highlighting the importance of regulating this damage tolerance pathway following fork stalling and throughout the cell cycle.
Links
LM2018127, research and development project |
|